🇺🇸 FDA
Patent

US 6884804

Inhibitors of Src and other protein kinases

expired A61KA61K9/0051A61P

Quick answer

US patent 6884804 (Inhibitors of Src and other protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Apr 26 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K9/0051, A61P, A61P1/04, A61P1/18